1. Decision Making Around Optimal Management of Liver-Limited Metastatic Colorectal Cancer

   • Robert P. Jones
   • Graeme J. Poston

   Colorectal Cancer 02 December 2015 Pages: 353 - 354

2. Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect?

   • Thomas N. Wang
   • Herbert Chen

   Endocrine Tumors 28 September 2015 Pages: 355 - 357

3. 2015 James Ewing Lecture: The 75-Year History of the Society of Surgical Oncology—Part II: The Transitional Years (1966–1990)

   • Charles M. Balch
   • Daniel G. Coit
   • Russell S. Berman

   Healthcare Policy and Outcomes 13 October 2015 Pages: 358 - 364

   

4. Splenic Preservation Versus Splenectomy During Distal Pancreatectomy: A Systematic Review and Meta-analysis

   • Ning Shi
   • Shang-Long Liu
   • Yu-Pei Zhao

   Healthcare Policy and Outcomes 22 October 2015 Pages: 365 - 374

   

5. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer

   • Michael A. Choti
   • Michele Thomas
   • Mark R. Green

   Colorectal Cancer 11 November 2015 Pages: 375 - 381

   

6. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms

   • Patricio M. Polanco
   • Ying Ding
   • Haroon A. Choudry

   Colorectal Cancer 01 October 2015 Pages: 382 - 390

   

7. OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan

   • Hirofumi Yamamoto
   • Naohiro Tomita
   • Nariaki Matsuura

   Colorectal Cancer 05 October 2015 Pages: 391 - 396

8. The Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada

   • Christine Keng
   • Angela Coates
   • Marko Simunovic

   Colorectal Cancer 15 October 2015 Pages: 397 - 402

   

9. Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer

   • Linda M. Youngwirth
   • Mohamed A. Adam
   • Julie A. Sosa

   Endocrine Tumors 28 September 2015 Pages: 403 - 409

   

10. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

    • Iain J. Nixon
    • Deborah Kuk
    • Jatin P. Shah

    Endocrine Tumors 28 July 2015 Pages: 410 - 415

    

11. Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure

    • Naris Nilubol
    • Lee S. Weinstein
    • Electron Kebebew

    Endocrine Tumors 05 November 2015 Pages: 416 - 423

    

12. The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas

    • Benjamin C. James
    • Briseis Aschebrook-Kilfoy
    • Raymon H. Grogan

    Endocrine Tumors 14 October 2015 Pages: 424 - 433

13. Which Surgical Attitude to Choose in the Context of Non-Resectability of Ovarian Carcinomatosis: Beyond Gross Residual Disease Considerations

    • Fabien Vidal
    • Haya Al Thani
    • Arash Rafii

    Gynecologic Oncology 05 November 2015 Pages: 434 - 442

    

14. New Pointers for Surgical Staging of Borderline Ovarian Tumors

    • Sofiane Bendifallah
    • Myriam Nikpayam
    • Emile Darai

    Gynecologic Oncology 05 August 2015 Pages: 443 - 449

    

15. The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma

    • Y. Naaman
    • L. Pinkas
    • A. Ben-Arie

    Gynecologic Oncology 05 October 2015 Pages: 450 - 455

    

16. Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital

    • Veronica Jones
    • Jared Linebarger
    • Monica Rizzo

    Breast Oncology 08 August 2015 Pages: 456 - 464

    

17. Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction

    • Jad M. Abdelsattar
    • Judy C. Boughey
    • Michel Saint-Cyr

    Breast Oncology 26 August 2015 Pages: 465 - 470

    

18. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer

    • Maria Karsten
    • Michelle Stempel
    • Tari A. King

    Breast Oncology 04 September 2015 Pages: 471 - 476

19. Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population

    • Siem A. Dingemans
    • Peter D. de Rooij
    • Anne E. M. van der Pool

    Breast Oncology Open access 14 September 2015 Pages: 477 - 481

    

20. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence

    • Gaiane M. Rauch
    • Brian P. Hobbs
    • Wei T. Yang

    Breast Oncology 28 September 2015 Pages: 482 - 489

    

21. Cost Analysis of Intraoperative Subareolar Frozen Section During Nipple-Sparing Mastectomy

    • Michael Alperovich
    • Scott M. Reis
    • Amber A. Guth

    Breast Oncology 05 October 2015 Pages: 490 - 493

22. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression

    • Mohamed El-Shinawi
    • Hossam Taha Mohamed
    • Mona Mostafa Mohamed

    Breast Oncology 27 October 2015 Pages: 494 - 502

    

23. Stoma Creation and Reversal After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    • Andrea N. Doud
    • Edward A. Levine
    • Konstantinos I. Votanopoulos

    Gastrointestinal Oncology 16 June 2015 Pages: 503 - 510

    

24. Surgical Resection of Remnant Gastric Cancer Following Distal Gastrectomy: A Retrospective Clinicopathological Study

    • Masashi Takahashi
    • Hiroya Takeuchi
    • Yuko Kitagawa

    Gastrointestinal Oncology 24 June 2015 Pages: 511 - 521

    

25. A Patent Cranial End of the Ductus Venosus Can Result in Hemorrhage when Performing a Lesser Omentectomy–Omental Bursectomy Procedure

    • Paul H. Sugarbaker

    Gastrointestinal Oncology 21 August 2015 Pages: 522 - 524

    

26. Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer

    • Katsunobu Sakurai
    • Masaichi Ohira
    • Kosei Hirakawa

    Gastrointestinal Oncology 26 August 2015 Pages: 525 - 533

    

27. Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries

    • Harveshp D. Mogal
    • Edward A. Levine
    • Konstantinos I. Votanopoulos

    Gastrointestinal Oncology 20 August 2015 Pages: 534 - 538

    

28. Impact of the Surveillance Interval on the Survival of Patients Who Undergo Curative Surgery for Gastric Cancer

    • Chan Hyuk Park
    • Jun Chul Park
    • Choong Bae Kim

    Gastrointestinal Oncology 30 September 2015 Pages: 539 - 545

    

29. S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer

    • Manabu Yamamoto
    • Yoshihisa Sakaguchi
    • Takeshi Okamura

    Gastrointestinal Oncology 06 October 2015 Pages: 546 - 551

    

30. Approach to the Porta Hepatis During Cytoreductive Surgery: Technical Considerations

    • N. Aydin
    • A. Sardi
    • V. Milovanov

    Gastrointestinal Oncology 17 November 2015 Pages: 552 - 555

    

31. Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study

    • Su-Lin Wang
    • Cheng-Le Zhuang
    • Zhen Yu

    Gastrointestinal Oncology 14 December 2015 Pages: 556 - 564

32. Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients

    • Anders Christensen
    • Karina Juhl
    • Christian von Buchwald

    Head and Neck Oncology Open access 14 October 2015 Pages: 565 - 572

    

33. Radiotherapy and Conservative Surgery in the Locoregional Management of Merkel Cell Carcinoma: The British Columbia Cancer Agency Experience

    • Chris Harrington
    • Winkle Kwan

    Melanomas 19 August 2015 Pages: 573 - 578

    

34. Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool

    • David E. Gyorki
    • Alexandra Sanelli
    • Michael A. Henderson

    Melanomas 15 October 2015 Pages: 579 - 584

    

35. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis

    • Thijs de Rooij
    • Johanna A. Tol
    • for the Dutch Pancreatic Cancer Group

    Pancreatic Tumors Open access 27 October 2015 Pages: 585 - 591

    

36. Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions

    • Terence C. Chua
    • Timothy X. Yang
    • Jaswinder S. Samra

    Pancreatic Tumors 26 August 2015 Pages: 592 - 599

    

37. Updated Evidence of Acellular Dermal Matrix Use for Implant-Based Breast Reconstruction: A Meta-analysis

    • Kyeong-Tae Lee
    • Goo-Hyun Mun

    Reconstructive Oncology 05 October 2015 Pages: 600 - 610

    

38. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma

    • Yukiko Niwa
    • Masahiko Koike
    • Yasuhiro Kodera

    Thoracic Oncology 20 August 2015 Pages: 611 - 618

    

39. Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database

    • Hao Fu
    • Zhi-Tao Gu
    • Ke-Neng Chen

    Thoracic Oncology 16 October 2015 Pages: 619 - 625

    

40. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?

    • Peter J. Kneuertz
    • Wayne L. Hofstetter
    • Brian Badgwell

    Thoracic Oncology 12 November 2015 Pages: 626 - 632

    

41. Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy

    • Fumihiro Shoji
    • Koji Yamazaki
    • Sadanori Takeo

    Thoracic Oncology 06 October 2015 Pages: 633 - 637

    

42. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm

    • Britt J. Sandler
    • Zuoheng Wang
    • Anthony W. Kim

    Thoracic Oncology 16 October 2015 Pages: 638 - 645

    

43. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis

    • Hariruk Yodying
    • Akihisa Matsuda
    • Eiji Uchida

    Thoracic Oncology 28 September 2015 Pages: 646 - 654

    

44. Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer

    • Stephanie Downs-Canner
    • Deepa Magge
    • David L. Bartlett

    Translational Research and Biomarkers 20 August 2015 Pages: 655 - 662

    

45. Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma

    • Seiya Hattori
    • Eiji Kikuchi
    • Mototsugu Oya

    Translational Research and Biomarkers 08 September 2015 Pages: 663 - 670

    

46. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer

    • Takayuki Yamaguchi
    • Yukihiro Yokoyama
    • Masato Nagino

    Translational Research and Biomarkers 28 September 2015 Pages: 671 - 677

    

47. The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer

    • Ryuma Tokunaga
    • Yasuo Sakamoto
    • Hideo Baba

    Translational Research and Biomarkers 28 September 2015 Pages: 678 - 685

    

48. Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality

    • Taekmin Kwon
    • In Gab Jeong
    • Choung-Soo Kim

    Urologic Oncology 06 October 2015 Pages: 686 - 693

    

49. Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status

    • Su-Jin Shin
    • Yoon Kyung Jeon
    • Heounjeong Go

    Urologic Oncology 13 October 2015 Pages: 694 - 702